Tumor cells circulating in the blood are the germ cells of breast cancer metastases. They are very rare and have not been ...

California based clinical-stage biopharmaceutical concern focused on the development of precision medicines that leverage its expertise in fibroblast growth factor receptor (FGFR) biology to treat ...

The January 10, 2017, article by Nogova et al, entitled “Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic ...

The following is a summary of “Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, ...